{
    "N/R/U": null,
    "Applicant": "Merck Sharp & Dohme LLC",
    "BLA Number": "125814",
    "Proprietary Name": "CAPVAXIVE",
    "Proper Name": "Pneumococcal 21-valent Conjugate Vaccine",
    "BLA Type": "351(a)",
    "Strength": "84UG/.5ML",
    "Dosage Form": "Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Pre-Filled Syringe",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "June 17, 2024",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "0002",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "June 17, 2024",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "June 17, 2036",
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "Pneumococcal 21-valent Conjugate Vaccine"
        }
    ]
}